Pieris Pharmaceuticals In...

NASDAQ: PIRS · Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 9:00 PM

Pieris Pharmaceuticals Revenue

Pieris Pharmaceuticals reported an annual revenue of $42.81M, reflecting a 65.28% growth. For the quarter ending September 30, 2024, Pieris Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
$42.81M
Revenue Growth
65.28%
Price / Sales Ratio
0.38
Revenue / Employee
$930.65K
Employees
46
Market Cap
17.96M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.